Cannabix Technologies Stock Gross Profit

BLOZF Stock  USD 0.27  0.02  6.90%   
Cannabix Technologies fundamentals help investors to digest information that contributes to Cannabix Technologies' financial success or failures. It also enables traders to predict the movement of Cannabix Pink Sheet. The fundamental analysis module provides a way to measure Cannabix Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabix Technologies pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cannabix Technologies Company Gross Profit Analysis

Cannabix Technologies' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Cannabix Technologies Gross Profit

    
  (6.6 M)  
Most of Cannabix Technologies' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabix Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Cannabix Technologies reported (6.6 Million) of gross profit. This is 100.29% lower than that of the Healthcare sector and 100.41% lower than that of the Medical Devices industry. The gross profit for all United States stocks is 100.02% higher than that of the company.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Cannabix Fundamentals

About Cannabix Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cannabix Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabix Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabix Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Cannabix Pink Sheet

Cannabix Technologies financial ratios help investors to determine whether Cannabix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannabix with respect to the benefits of owning Cannabix Technologies security.